GNB3 encodes the G protein subunit beta 3, a critical component of heterotrimeric G proteins essential for transmembrane signaling. As part of the G protein complex, GNB3 facilitates GTPase activity, GDP-GTP exchange, and G protein-effector interactions 1. The protein regulates diverse cellular processes including glucose metabolism, hormone signaling, blood pressure control, and fat cell differentiation 1. GNB3's primary disease association is congenital stationary night blindness type 1H, resulting from pathogenic variants disrupting phototransduction in retinal cells 1. Additionally, GNB3 expression marks medullary thymic epithelial cells in thymic epithelial tumors, potentially predicting tumor immunological behavior 2. The common C825T polymorphism (rs5443) shows associations with metabolic and cardiovascular phenotypes. The TT genotype correlates with increased obesity risk and elevated leptin levels 3. Gene-environment interaction studies reveal that in physically inactive African Americans, the 825T allele associates with 23% greater obesity prevalence, while active carriers show 20% lower obesity risk 4. The maternal 825T variant also increases pre-eclampsia risk 5. However, GNB3 polymorphisms show no significant association with antipsychotic-induced weight gain 6 or endurance athlete status 7. The variant may influence triptan treatment response in cluster headache patients 8.